Long non-coding RNA KCNQ1OT1 promotes ovarian cancer cell malignant characteristics by targeting the miR-140-5p/KLK10

Renjie Duan1, Zhenyu Tao2, Shun Tao3

  • 1School of Preclinical Medicine, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.

Insights

Long non-coding RNA KCNQ1OT1 promotes ovarian cancer progression by regulating the miR-140-5p/KLK10 pathway. This study reveals a novel regulatory axis, advancing understanding of lncRNA in ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) are critical regulators of cancer progression.
  • The specific roles of many lncRNAs in ovarian cancer (OC) are not well understood.
  • KCNQ1OT1 is a lncRNA implicated in cancer, but its function in OC requires elucidation.

Purpose of the Study:

  • To investigate the role and molecular mechanisms of KCNQ1OT1 in ovarian cancer progression.
  • To identify potential regulatory pathways involving KCNQ1OT1, microRNAs, and target genes in OC.
  • To explore KCNQ1OT1 as a potential therapeutic target in ovarian cancer.

Main Methods:

  • Bioinformatic analysis (TargetScan, starBase) to predict interactions.
  • Experimental validation of interactions using miRNA pull-down assays.
  • Gene expression analysis (RT-qPCR) and functional assays (CCK-8, wound-healing) in OC cell lines.

Main Results:

  • KCNQ1OT1 and KLK10 were upregulated, while miR-140-5p was downregulated in OC tissues and cells.
  • Silencing KCNQ1OT1 inhibited OC cell proliferation and migration.
  • KCNQ1OT1 promoted OC progression by modulating the miR-140-5p/KLK10 axis.

Conclusions:

  • KCNQ1OT1 acts as an oncogenic lncRNA in ovarian cancer.
  • A novel regulatory axis (KCNQ1OT1/miR-140-5p/KLK10) drives OC cell proliferation and migration.
  • KCNQ1OT1 represents a potential therapeutic target for ovarian cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K